Recent Articles from GlobeNewswire

MEXC January Newly Listed Token Spot Trading Volume Surges 65% as Crypto Markets Enter New Infrastructure Cycle
By MEXC · Via GlobeNewswire · February 5, 2026
GXO Accelerates Aerospace & Defence Expansion with BAE Systems Renewal in UK
BAE Systems and GXO to extend relationship into its third decade
By GXO Logistics · Via GlobeNewswire · February 5, 2026
MEXC Launches Commodity Zero-Fee Gala with $1 Million in Trading Rewards
By MEXC · Via GlobeNewswire · February 5, 2026
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB
GE Medical Holding AB exercises all its Warrants in EXACT Therapeutics resulting in gross proceeds of NOK 33 million.
By Exact Therapeutics AS · Via GlobeNewswire · February 5, 2026
PONY AI Inc. to Hold Extraordinary General Meeting on April 2, 2026
GUANGZHOU, China, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Pony AI Inc. (“Pony.ai” or the “Company”) (NASDAQ: PONY; HKEX: 2026), a global leader in achieving large-scale mass production and commercialization of autonomous driving technology, today announced that it will hold an extraordinary general meeting of the Company’s shareholders (the “EGM”) at 11:00 a.m. (Beijing time), or shortly after the Class A Meeting and Class B Meeting (which are defined below) are concluded, on April 2, 2026 at 1/F, Building 8, Phase II, Datang Industrial Park, Huangge Town, Nansha District, Guangzhou, Guangdong Province, PRC, for the purposes of considering and, if thought fit, passing each of the Proposed Resolutions as defined and set forth in the notice of the EGM (the “EGM Notice”). The EGM Notice and the form of proxy for the EGM are available on the Company’s website at https://ir.pony.ai. The board of directors of the Company fully supports the Proposed Resolutions and recommends that shareholders and holders of American depositary shares (“ADSs”) vote in favor of the Proposed Resolutions.
By Pony AI Inc. · Via GlobeNewswire · February 5, 2026
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
REYKJAVIK, Iceland, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a pharmacokinetic (PK) study for AVT80, a biosimilar candidate to Entyvio® (vedolizumab).
By Alvotech · Via GlobeNewswire · February 5, 2026
Community Psychometrics Unveils Internet's Most Accurate Online IQ Test
Community Psychometrics Sets a New Benchmark for Online IQ Testing
By Community Psychometrics · Via GlobeNewswire · February 5, 2026
Shell announces commencement of a share buyback programme
Shell plc
By Shell plc · Via GlobeNewswire · February 5, 2026
Shell plc Fourth Quarter 2025 Interim Dividend
Shell plc Fourth Quarter 2025 Interim Dividend    
By Shell plc · Via GlobeNewswire · February 5, 2026
Shell plc publishes fourth quarter 2025 press release
London, February 5, 2026
By Shell plc · Via GlobeNewswire · February 5, 2026
Shell Plc 4th Quarter 2025 and Full Year Unaudited Results
By Shell plc · Via GlobeNewswire · February 5, 2026
FTI Consulting Adds Two Senior Chemicals Experts to Transformation Practice
FRANKFURT, Germany, Feb. 05, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) has further strengthened its Transformation practice with the addition of two senior chemicals experts. Mark Reimer has been appointed as a Senior Managing Director, while Dr. Alexander Keller joins the firm as a Managing Director.
By FTI Consulting, Inc. · Via GlobeNewswire · February 5, 2026
Update on management changes
Update on management changes
By ING Group · Via GlobeNewswire · February 5, 2026
ArcelorMittal reports fourth quarter 2025 and full year 2025 results
Luxembourg, February 5, 2026 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated steel and mining company, today announced results1 for the three-month and twelve-month periods ended December 31, 2025
By ArcelorMittal S.A. · Via GlobeNewswire · February 5, 2026
WISeKey, WISeSat and Latitude Join Forces to Prepare a Future Secure IoT Satellite Constellation
 
Canon's PowerShot Compact Digital Camera Turns 30
Limited Edition PowerShot G7 X Mark III Camera Available
By Canon U.S.A., Inc. · Via GlobeNewswire · February 4, 2026
Canon Continues Wide Angle Optical Excellence with Launch of RF7-14mm F2.8-3.5 L Fisheye STM Zoom Lens and RF14mm F1.4 L VCM Prime Lens
Melville, NY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Canon U.S.A., Inc., a leader in digital imaging solutions, today announced the launch of the RF7-14mm F2.8-3.5 L Fisheye STM zoom lens and the RF14mm F1.4 L VCM prime lens. Building on Canon's legacy of innovative optics, these new RF-mount lenses expand the diverse lineup for professional photographers, videographers, and hybrid creators. The RF7-14mm F2.8-3.5 L Fisheye STM zoom lens introduces the world's widest angle zoom lens1 with a 190° field of view, ideal for dynamic fisheye imagery in sports, landscapes, and virtual reality. The RF14mm F1.4 L VCM prime lens delivers Canon’s brightest ultra-wide1 angle interchangeable lens ever produced, a 14mm lens with a bright f/1.4 aperture, perfect for astro, architecture, and video applications.
By Canon U.S.A., Inc. · Via GlobeNewswire · February 4, 2026
Canon 14mm F1.4 Ultra-Wide and RF 7-14mm f/2.8-3.5 L Fisheye STM Just Announced: YouTube First Look Video and Preorder at B&H Photo
Canon’s newest wide-angle lenses for the RF mount, the 14mm f/1.4 L VCM ultra-wide prime and the Canon 7-14mm f/2.8-3.5 L Fisheye STM zoom lens
By B&H Photo Video · Via GlobeNewswire · February 4, 2026
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
MILLBRAE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, innovative medicines to address serious unmet medical needs, today announced the pricing of its upsized initial public offering of 21,177,600 shares of its common stock at an initial public offering price of $18.00 per share. In addition, Eikon has granted the underwriters a 30-day option to purchase up to an additional 3,176,640 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The gross proceeds to Eikon from the offering, without giving effect to the underwriters’ option to purchase additional shares and before deducting underwriting discounts and commissions and offering expenses payable by Eikon, are expected to be approximately $381 million.
By Eikon Therapeutics, Inc. · Via GlobeNewswire · February 4, 2026
Figure Technology Solutions Reports January Operating Data
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR), the leading blockchain-native capital marketplace for the origination, funding, sale and trading of tokenized assets, today reported select operating data for the month ended January 31, 2025.
By Figure Technology Solutions, Inc. · Via GlobeNewswire · February 4, 2026
Citizens Business Bank Recognized by Forbes as a Best Bank in America for 2026
ONTARIO, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- CVB Financial Corp. (NASDAQ: CVBF), the holding company for Citizens Business Bank, N.A. (the “Bank”), has been recognized by Forbes in the publication’s seventeenth annual America’s Best Banks list. This recognition represents the ninth time in the past decade that the Bank has been included on Forbes’ list of the best banks in the nation.
By CVB Financial Corp · Via GlobeNewswire · February 4, 2026
LGI Homes, Inc. Reports January 2026 Home Closings
THE WOODLANDS, Texas, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced it closed 218 homes in January 2026, which includes the closing of 16 currently or previously leased single-family rental homes.
By LGI Homes, Inc. · Via GlobeNewswire · February 4, 2026
Novarad to Attend 2026 Society of Interventional Oncology Annual Scientific Meeting in Savannah, Georgia
Highlighting VisAR® Augmented Reality Surgical Navigation at SIO 2026
By Novarad Corporation · Via GlobeNewswire · February 4, 2026
Americans Crave More Time Outdoors at Home, But Their Homes Aren’t Built for It
MISSION, Kan., Feb. 04, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) For many Americans, outdoor space is no longer viewed as an occasional seasonal perk. Backyards, patios and decks are increasingly seen as extensions of everyday living, places for relaxing, gathering and entertaining. Yet for many homeowners, outdoor time still ends earlier than they would like.
By Feature Impact · Via GlobeNewswire · February 4, 2026
ARDT INVESTOR ALERT: Contact Kirby McInerney LLP About Securities Class Action Lawsuit On Behalf of Ardent Health, Inc. Investors
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE:ARDT) investors of the March 9, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Ardent securities between July 18, 2024 through November 12, 2025 (“the Class Period”).
By Kirby McInerney LLP · Via GlobeNewswire · February 4, 2026
RR SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Richtech Robotics Inc. Investors - Contact Kirby McInerney LLP by April 3, 2026
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Richtech Robotics Inc. (“Richtech” or the “Company”) (NASDAQ:RR) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · February 4, 2026
CN’s 2025 Annual Financial Statements and Annual Information Form available on Company Website
MONTREAL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that the Company’s 2025 Annual Financial Statements, Notes thereto and Management’s Discussion and Analysis, and its 2025 Annual Information Form and Form 40-F, have been filed with Canadian and U.S. securities regulators and are now available in the “Investors” section of its website, www.cn.ca/investors.
By Canadian National Railway Company · Via GlobeNewswire · February 4, 2026
Dave’s Hot Chicken Turns Up the Heat for the Big Game With First-Ever Super Bowl Ad, Major Sports Partnerships, and Fan-Fueled Moments
The cult-favorite brand debuts its biggest advertising moment yet, launches a $10,000 Championship Heat Check with DraftKings and teams up with Bleacher Report
By Dave's Hot Chicken · Via GlobeNewswire · February 4, 2026
Bragar Eagel & Squire, P.C. Urges Vistagen Therapeutics, Inc. Stockholders to Contact the Firm Regarding The Upcoming Lead Plaintiff Deadline for the Filed Class Action Lawsuit
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vistagen (VTGN) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · February 4, 2026
Norton Rose Fulbright enhances US privacy, AI and cyber capabilities with San Francisco partner hire
Helen Christakos joins as demand continues to grow for privacy compliance, AI governance and cybersecurity risk counseling
By Norton Rose Fulbright · Via GlobeNewswire · February 4, 2026
Bitdeer Announces Fourth Quarter 2026 Earnings Conference Call For February 12th 2026
SINGAPORE, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for Bitcoin mining and AI infrastructure, today announced that it has scheduled its fourth quarter 2025 earnings conference call and webcast for Thursday, February 12, 2026 at 8:00 AM EST. During the call, Bitdeer management will discuss the unaudited financial and operational results for the quarter ended December 31, 2025, followed by a question-and-answer session.
By Bitdeer Technologies Group · Via GlobeNewswire · February 4, 2026
Verity and Bushel Announce Integration to Advance Traceable Agricultural Practices Across the Supply Chain
ENGLEWOOD, Colo. and FARGO, N.D., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Verity Holdings, LLC, a wholly owned subsidiary of Gevo, Inc. (NASDAQ: GEVO), and Bushel today announced an integration that will connect Bushel’s on-farm data with Verity’s sustainability modeling and compliance platform. This integration supports the traceability and documentation of agricultural production practices that can influence carbon intensity outcomes and increase credit value under Section 45Z. It also helps position the agricultural supply chain for evolving carbon programs and market-based opportunities for traceable grain.
By Gevo, Inc. · Via GlobeNewswire · February 4, 2026
CORCEPT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Encourages Corcept Therapeutics Investors to Contact the Firm Regarding Ongoing Investigation
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Corcept (CORT) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · February 4, 2026
Integra Announces US$55 Million Bought Deal Financing
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+
By Integra Resources Corp. · Via GlobeNewswire · February 4, 2026
WEALTHFRONT (NASDAQ:WLTH) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Wealthfront Corporation on Behalf of Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Wealthfront (WLTH) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · February 4, 2026
Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement
CINCINNATI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the filing of its definitive proxy statement and management information circular (the “Circular”) in connection with Quipt’s upcoming special meeting (the “Meeting”) of the holders (the “Shareholders”) of Quipt’s common shares (the “Shares”) to be held on March 3, 2026, at 10:00 a.m. (Eastern Standard Time). The Circular is available under Quipt’s profile on SEDAR+ at www.sedarplus.com, with the U.S. Securities and Exchange Commission (the “SEC”) on the EDGAR website at www.sec.gov, and on Quipt’s website at https://quipthomemedical.com/sec-filings/. Mailing to Shareholders of the Circular and related materials for the Meeting (collectively, the “Meeting Materials”) has also commenced and Shareholders should receive the Meeting Materials shortly. The Meeting is being held for Shareholders to consider and vote on a special resolution (the “Arrangement Resolution”) approving a plan of arrangement (the “Arrangement”) pursuant to which affiliates of Kingswood Capital Management, L.P. (“Kingswood”) and Forager Capital Management, LLC, will acquire all of the issued and outstanding Shares for cash consideration of US$3.65 per Share, representing a 54% premium to Quipt’s 30-day VWAP as of December 12, 2025, the last trading day prior to the announcement of the Arrangement, all as more fully described in the Circular.
By Quipt Home Medical Corp. · Via GlobeNewswire · February 4, 2026
Cipher Mining Inc. Announces Pricing of $2.0 Billion of Senior Secured Notes
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a leading developer and operator of industrial-scale data centers, today announced that its wholly-owned subsidiary, Black Pearl Compute LLC (the “Issuer”), has priced a $2.0 billion offering of 6.125% senior secured notes due 2031 (the “Notes”) at par. The Notes will be sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) and to non-U.S. persons outside of the United States pursuant to Regulation S under the Securities Act. The offering is expected to close on February 11, 2026, subject to market and other conditions.
By Cipher Mining Inc. · Via GlobeNewswire · February 4, 2026
Diamond Residential Mortgage Corporation Named a Top 50 Best Mortgage Company to Work For
National Recognition Highlights DRMC’s Culture, Operational Support, and Long-Term Platform
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
BRISBANE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company with a pipeline of advanced strategic therapeutic assets, today announced the closing of a previously announced transaction pursuant to which Tempest acquired certain dual-targeting chimeric antigen receptor (CAR)-T programs and obtained financing support from Factor Bioscience Inc. and its affiliates (collectively, “Factor”) in an all-stock transaction resulting in a diverse portfolio including clinical-stage product candidates and an extended runway with multiple potential near-term milestones (the “Transaction”).
By Tempest Therapeutics · Via GlobeNewswire · February 4, 2026
NorthStrive® Companies Inc. Co-Advises on Acquisition of SVM Machining, Inc.
NEWPORT BEACH, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- NorthStrive® Companies Inc. (“NorthStrive”), a management, advisory, and investment firm, is pleased to announce that it served as co-advisor to PMGC Holdings Inc. (“PMGC”) in connection with the successful acquisition of SVM Machining, Inc., a California-based precision manufacturing company.
By NorthStrive Companies Inc. · Via GlobeNewswire · February 4, 2026
Phoenix Education Partners, Inc. Announcement: If You Have Suffered Losses in Phoenix Education Partners, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 4, 2026
Bragar Eagel & Squire, P.C. Urges Bath & Body Works, Inc. (NYSE:BBWI) Stockholders with Significant Losses to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Bath & Body Works (BBWI) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · February 4, 2026
James River to Hold Its Fourth Quarter Earnings Conference Call on Tuesday, March 3, 2026
CHAPEL HILL, N.C., Feb. 04, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) will release fourth quarter earnings after the market closes on Monday, March 2, 2026. It will also host an earnings conference call on Tuesday, March 3, 2026 beginning at 8:30 a.m. (Eastern Time).
By James River Group Holdings, Inc. · Via GlobeNewswire · February 4, 2026
NorthStrive Biosciences Announces Progress Updates to Phase III Timeline for AI-Driven Drug Discovery Program with Yuva Biosciences
NEWPORT BEACH, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences Inc. (“NorthStrive Biosciences”), a subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB) (“PMGC”), today announced a progress update to the anticipated completion timeline for Phase III of its AI Development Program with strategic partner Yuva Biosciences, Inc. (“Yuva Biosciences”).
By PMGC Holdings Inc. · Via GlobeNewswire · February 4, 2026
STERIS Announces Financial Results for Fiscal 2026 Third Quarter
DUBLIN, IRELAND, Feb. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 third quarter ended December 31, 2025. Total revenue from continuing operations for the third quarter of fiscal 2026 increased 9% to $1.5 billion compared with $1.4 billion in the third quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations for the third quarter was 8%.
By STERIS plc · Via GlobeNewswire · February 4, 2026
Orangekloud Technology Inc. Announces Nasdaq Delisting Determination Letter
Singapore, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (NASDAQ: ORKT) (“Orangekloud” or the “Company”), a Singapore-based technology company offering the eMOBIQ®️ No-Code platform for development of mobile applications, today announced that, on January 29, 2026, it received a Staff Delisting Determination Letter from the staff of Nasdaq Listing Qualifications (the “Staff”).
By Orangekloud Technology Inc. · Via GlobeNewswire · February 4, 2026
Olema Oncology to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following upcoming investor conferences:
By Olema Oncology · Via GlobeNewswire · February 4, 2026
BELLRING CLASS ACTION LAWSUIT REMINDER: Bragar Eagel & Squire, P.C. Reminds BellRing Brands (NYSE:BRBR) Investors to Contact the Firm Regarding Their Rights
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BellRing (BRBR) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · February 4, 2026
Sun Communities Announces Chief Financial Officer Transition
Southfield, MI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment trust ("REIT") that owns and operates, or has an interest in, manufactured housing (“MH”) and recreational vehicle (“RV”) communities (collectively, the "properties"), today announced a leadership transition. Effective immediately, following the departure of Mark E. Patten, Fernando Castro-Caratini has assumed the role of Chief Financial Officer on an interim basis. The Company is conducting a broad search to identify a permanent Chief Financial Officer.
By Sun Communities, Inc. · Via GlobeNewswire · February 4, 2026
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 4, 2026
Banner Health names new senior vice president of finance
Shelby Arveson to oversee finance strategy across Banner’s integrated delivery system
By Banner Health · Via GlobeNewswire · February 4, 2026
DHT Holdings, Inc. Fourth Quarter 2025 Results
HAMILTON, BERMUDA, February 4, 2026 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced its results for the quarter ended December 31, 2025.
By DHT Holdings, Inc. · Via GlobeNewswire · February 4, 2026
Costco Wholesale Corporation Reports January Sales Results
ISSAQUAH, Wash., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $21.33 billion for the retail month of January, the four weeks ended February 1, 2026, an increase of 9.3 percent from $19.51 billion last year.
By Costco Wholesale Corporation · Via GlobeNewswire · February 4, 2026
SiriusPoint Announces Date for Fourth Quarter 2025 Earnings Release
HAMILTON, Bermuda, Feb. 04, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (NYSE: SPNT) (“SiriusPoint” or the “Company”) today announced that it is planning to release its fourth quarter 2025 financial results after the market close on Wednesday, February 18, 2026. The Company will also hold a conference call, including a question-and-answer session, to discuss its financial results at 8:30 am (Eastern Time) on Thursday, February 19, 2026.
By SiriusPoint Ltd. · Via GlobeNewswire · February 4, 2026
Natural Resource Partners L.P. Declares Fourth Quarter 2025 Distribution
HOUSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Natural Resource Partners L.P. (NYSE: NRP) today announced that the board of directors of its general partner declared a fourth quarter 2025 distribution of $0.75 per common unit for NRP. The distribution will be paid on February 24, 2026 to unitholders of record on February 17, 2026. Future distributions on NRP's common units will be determined on a quarterly basis by the board of directors. The board of directors considers numerous factors each quarter in determining cash distributions including profitability, cash flow, debt service obligations, market conditions and outlook, estimated unitholder income tax liability, and the level of cash reserves that the board determines is necessary for future operating and capital needs.
By Natural Resource Partners LP · Via GlobeNewswire · February 4, 2026
Four Tatari clients to Air Commercials During NBC’s Super Bowl LX Broadcast, Underscoring Its Role as the Go-To Partner for TV Advertising at Scale
Ro, Manscaped, Tecovas, and Life360 to Air Commercials During NBC’s Super Bowl LX Broadcast
By Tatari Inc. · Via GlobeNewswire · February 4, 2026
Pepper Lunch Introduces New Kids Menu, Expanding Family-Friendly Dining Experience
Permanent menu addition offers kid-friendly portions, familiar flavors, and enhanced safety for younger guests
By Pepper Lunch · Via GlobeNewswire · February 4, 2026
Rumble Unveils the Web Version of Rumble Shorts
LONGBOAT KEY, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) --  Rumble Inc. (NASDAQ:RUM), the Freedom-First technology platform, has unveiled Rumble Shorts, the platform’s home for short-form videos, on the web at rumble.com/shorts. The mobile app versions will follow later this month pending approval by the app stores.
By Rumble, Inc. · Via GlobeNewswire · February 4, 2026
SiTime to Acquire Renesas’ Timing Business
SANTA CLARA, Calif. and TOKYO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- SiTime Corporation (Nasdaq: SITM) (“SiTime” or the “Company”), the Precision Timing company, and Renesas Electronics Corporation (TSE: 6723) (“Renesas”), a premier supplier of advanced semiconductors, today announced that SiTime and Renesas’ consolidated subsidiary, Renesas Electronics America Inc., have signed a definitive agreement whereby SiTime will acquire certain assets related to Renesas’ timing business. The acquisition accelerates SiTime’s path to $1 billion of revenue as the premier pure-play Precision Timing company with an industry leading portfolio to fully meet customers’ needs for high-performance timing products. Additionally, the companies have signed a partnership MOU to explore SiTime’s MEMS resonator integration into Renesas’ embedded computing products.
Coca-Cola Consolidated, Inc. to Release Fourth Quarter and Fiscal Year 2025 Results
CHARLOTTE, N.C., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Coca-Cola Consolidated, Inc. (NASDAQ: COKE) will issue a news release after the market closes on February 18, 2026 to announce its operating results for the fourth quarter and fiscal year ended December 31, 2025.
By Coca-Cola Consolidated, Inc. · Via GlobeNewswire · February 4, 2026
SiTime Reports Fourth Quarter and Fiscal Year 2025 Financial Results
SANTA CLARA, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- SiTime Corporation, (Nasdaq: SITM), the Precision Timing company, today announced financial results for the fourth quarter and financial year ended December 31, 2025.
By SiTime · Via GlobeNewswire · February 4, 2026
ARRAY Technologies Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
ALBUQUERQUE, N.M., Feb. 04, 2026 (GLOBE NEWSWIRE) -- ARRAY Technologies, Inc. (the “Company” or “ARRAY”) (NASDAQ: ARRY), a leading global provider of solar tracking technology products, software, services and foundation solutions, today announced that the Company will release its fourth quarter and full year 2025 results after the market closes on Wednesday, February 25, 2026, to be followed by a conference call at 5:00 p.m. (Eastern Time) that same day.
By Array Technologies, Inc. · Via GlobeNewswire · February 4, 2026
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2025 Financial Results
LOS ANGELES, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025 on Wednesday, February 18, 2026 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Thursday, February 19, 2026 at 12:00 p.m. Eastern Time to discuss its fourth quarter and year ended December 31, 2025 financial results.
By Crescent Capital BDC · Via GlobeNewswire · February 4, 2026
Mister Car Wash to Report Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
TUCSON, Ariz., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Mister Car Wash, Inc. (the "Company" or "Mister"; Nasdaq: MCW), the nation’s leading car wash brand, today announced that its financial results for the fourth quarter and full year of 2025 will be released after market close on Wednesday, February 18, 2026. On the same day, the Company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results.
By Mister Car Wash · Via GlobeNewswire · February 4, 2026
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026
ORLANDO, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 fourth quarter and full year financial results before the market opens on Tuesday, February 10, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.
By iRadimed Corporation · Via GlobeNewswire · February 4, 2026
Alico, Inc. Announces Financial Results for the First Quarter Ended December 31, 2025
Company Closed $7.7 million of Land Sales in First Quarter; Total Land Sales Reach $34.5 million Year-to-Date Through January 2026
By Alico, Inc. · Via GlobeNewswire · February 4, 2026
Coherent Corp. Reports Second Quarter Fiscal 2026 Results
SAXONBURG, Pa., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR) (“Coherent,” “We,” or the “Company”), a global leader in photonics, announced financial results today for its second quarter of fiscal year 2026 ended December 31, 2025.
By Coherent Corp. · Via GlobeNewswire · February 4, 2026
Tenable Announces Fourth Quarter and Full Year 2025 Financial Results
Tenable exceeds all guided metrics for the fourth quarter and full year 2025, announces increase of $150 million to share repurchase authorization
By Tenable Holdings, Inc. · Via GlobeNewswire · February 4, 2026
Kodiak to Present at Upcoming Investor Conference
MOUNTAIN VIEW, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Kodiak AI (Nasdaq: KDK), a leading provider of AI-powered autonomous vehicle technology, today announced that the company will present at the following investor conference:
By Kodiak AI, Inc. · Via GlobeNewswire · February 4, 2026
DoubleVerify to Participate in Upcoming Investor Conferences
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DoubleVerify (“DV”) (NYSE: DV), a leading software platform for digital media measurement, data and analytics, today announced that Mark Zagorski, CEO, and Nicola Allais, CFO, will participate in the following investor conferences:
By DoubleVerify Inc. · Via GlobeNewswire · February 4, 2026
The Howard Hughes Corporation Prices Offering of Senior Notes
THE WOODLANDS, Texas, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Howard Hughes Holdings Inc. (NYSE: HHH) (“Howard Hughes,” “HHH,” or the “Company”) announced today the pricing by its wholly owned subsidiary, The Howard Hughes Corporation (“HHC”), of $500 million aggregate principal amount of senior notes due 2032 (the “2032 Notes”) and $500 million aggregate principal amount of senior notes due 2034 (the “2034 Notes” and, together with the 2032 Notes, the “Notes”). The Notes were priced at par.
By Howard Hughes Holdings Inc. · Via GlobeNewswire · February 4, 2026
Lesaka’s Q2 FY2026 Results: Lesaka achieves mid-point of its profitability guidance and reaffirms its FY2026 full year guidance
JOHANNESBURG, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the second quarter of fiscal 2026 (“Q2 2026”).
By Lesaka Technologies · Via GlobeNewswire · February 4, 2026
Fluence Energy, Inc. Reports First Quarter 2026 Results; Reaffirms Fiscal Year 2026 Guidance
ARLINGTON, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (Nasdaq: FLNC) (“Fluence” or the “Company”), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced its results for the three months ended December 31, 2025.
By Fluence · Via GlobeNewswire · February 4, 2026
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
CAMBRIDGE, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced that management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026 at 10:30 a.m. ET.
By Relay Therapeutics, Inc. · Via GlobeNewswire · February 4, 2026
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Cambridge, Massachusetts, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced the company will be participating in a fireside chat and investor one-on-one meetings at the Guggenheim Emerging Outlook: Biotech Summit 2026 being held from February 11-12th, 2026 in New York, NY.
By ProMIS Neurosciences Inc. · Via GlobeNewswire · February 4, 2026